MedTrace Logo

Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection

NCT02424461 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 274

Last updated 2024-05-01

No results posted yet for this study

Summary

This study will investigate the treatment of urinary tract infection (UTI) in men. The investigators are looking to see if shorter duration of antibiotics (7 days) is not inferior to a longer duration of antibiotics (14 days). The investigators will also study whether longer treatment leads to an increase in antibiotic resistant bacteria in the gut microbiota or an increase in drug side effects.

Conditions

  • Acute Male Urinary Tract Infection

Interventions

DRUG

Ceftriaxone

1 injection 1 g per day for 2 days

DRUG

Ofloxacine

400 mg/jour (200 mg/ jour in case of renal failure) for seven days

DRUG

Ofloxacine

400 mg/jour (200 mg/ jour in case of renal failure) for 14 days

DRUG

Placebo of ofloxacine

Placebo of ofloxacine for 7 days

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-25
Primary Completion
2019-02-25
Completion
2019-07-25

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02424461 on ClinicalTrials.gov